T. Rowe Price Associates’s Perspective Therapeutics CATX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$177K Buy
42,282
+12,513
+42% +$52.9K ﹤0.01% 2876
2025
Q4
$82K Hold
29,769
﹤0.01% 2969
2025
Q3
$103K Buy
29,769
+978
+3% +$3.56K ﹤0.01% 2915
2025
Q2
$100K Buy
28,791
+5,351
+23% +$14.1K ﹤0.01% 2892
2025
Q1
$50K Buy
23,440
+3,748
+19% +$11.2K ﹤0.01% 2933
2024
Q4
$63K Buy
19,692
+1,784
+10% +$14.6K ﹤0.01% 2901
2024
Q3
$240K Buy
17,908
+2,889
+19% +$38.4K ﹤0.01% 2574
2024
Q2
$0 Buy
+15,019
New +$217K ﹤0.01% 2943
2022
Q1
Sell
-6,150
Closed -$24K 2986
2021
Q4
$24K Hold
6,150
﹤0.01% 2955
2021
Q3
$39K Hold
6,150
﹤0.01% 2913
2021
Q2
$49K Hold
6,150
﹤0.01% 2900
2021
Q1
$67K Buy
+6,150
New +$92.9K ﹤0.01% 2806

Other funds holding CATX